Retraction notice to "A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells".

导出 LinkOut

翻译打印收藏纠错

第一作者： Pramod P,Mehta

第一单位： Pfizer Worldwide Research and Development, Oncology Research, 10724 Science Center Drive, San Diego, CA 92121, United States.

作者： Pramod P,Mehta ^[1] ; Pei-Pei,Kung ^[1] ; Shinji,Yamazaki ^[1] ; Marlena,Walls ^[1] ; Andrea,Shen ^[1] ; Leslie,Nguyen ^[1] ; Michael R,Gehring ^[1] ; Gerrit,Los ^[1] ; Tod,Smeal ^[1] ; Min-Jean,Yin ^[1]

作者单位： Pfizer Worldwide Research and Development, Oncology Research, 10724 Science Center Drive, San Diego, CA 92121, United States. ^[1]

DOI 10.1016/j.canlet.2018.03.019

PMID 29579439

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Cancer letters

2018年422卷

132页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Retraction notice to "A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells".

Cancer letters

相似文献

Cancer letters

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Retraction notice to "A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells".

Cancer letters

相似文献

Cancer letters

相关期刊

检索历史清除